Two Leaders, One Vision:
Redefining Global Aesthetics
In 2023, ExoCoBio and BENEV joined forces to redefine global aesthetics. This strategic merger combines ExoCoBio’s expertise in exosome-based regenerative medicine with BENEV’s leadership in the medical aesthetics market. Together, we are driving innovation, expanding global reach, and delivering unparalleled value to our partners and clients.
The partnership between ExoCoBio and BENEV represents a powerful synergy of science, innovation, and market leadership. Together, we are shaping the future of regenerative aesthetics by combining cutting-edge exosome technology with a relentless commitment to quality and results.
About BENEV
Founded in 2000, BENEV Company Inc. is an FDA-registered pharmaceutical, cosmeceutical, and medical device company dedicated to serving the global medical aesthetics market. With a mission to "BENefit EVeryone," BENEV focuses on scientifically advanced, results-driven solutions that optimize skin health.
Our Mission: To inspire a more vibrant life and create a more beautiful world by providing products and services that revive, restore, and renew.
Our Approach: We go beyond fads and hype, analyzing the facts behind claims to deliver proven, effective solutions. We share our knowledge and expertise through education and training programs that focus on giving our customers the tools they need to build their businesses through aesthetic services and retail.
Leadership: Under the guidance of CEO Ethan Min, BENEV has built a reputation for integrity, creativity, and passion in the pursuit of excellence.
About ExoCoBio
Headquartered in South Korea, ExoCoBio is a global leader in exosome-based technology, specializing in regenerative medicine, biomedicine, and immuno-oncology. With its proprietary ExoSCRT™ technology, ExoCoBio produces high-purity, high-efficiency exosome-based solutions that are transforming both the cosmetic and medical industries.
Our Expertise: ExoCoBio operates a cGMP-certified facility to ensure the highest standards of quality and safety.
Innovative Products: From ASCE+ for skin and hair regeneration to next-generation cosmetic ingredients, ExoCoBio is at the forefront of exosome innovation.
Leadership: Led by CEO Byong Cho, ExoCoBio continues to pioneer advancements in exosome technology, improving lives through science.
.png)
.png)
Two Leaders, One Vision:
Redefining Global Aesthetics
In 2023, ExoCoBio and BENEV joined forces to redefine global aesthetics. This strategic merger combines ExoCoBio’s expertise in exosome-based regenerative medicine with BENEV’s leadership in the medical aesthetics market. Together, we are driving innovation, expanding global reach, and delivering unparalleled value to our partners and clients.
The partnership between ExoCoBio and BENEV represents a powerful synergy of science, innovation, and market leadership. Together, we are shaping the future of regenerative aesthetics by combining cutting-edge exosome technology with a relentless commitment to quality and results.
About BENEV
Founded in 2000, BENEV Company Inc. is an FDA-registered pharmaceutical, cosmeceutical, and medical device company dedicated to serving the global medical aesthetics market. With a mission to "BENefit EVeryone," BENEV focuses on scientifically advanced, results-driven solutions that optimize skin health.
Our Mission: To inspire a more vibrant life and create a more beautiful world by providing products and services that revive, restore, and renew.
Our Approach: We go beyond fads and hype, analyzing the facts behind claims to deliver proven, effective solutions. We share our knowledge and expertise through education and training programs that focus on giving our customers the tools they need to build their businesses through aesthetic services and retail.
Leadership: Under the guidance of CEO Ethan Min, BENEV has built a reputation for integrity, creativity, and passion in the pursuit of excellence.
About ExoCoBio
Headquartered in South Korea, ExoCoBio is a global leader in exosome-based technology, specializing in regenerative medicine, biomedicine, and immuno-oncology. With its proprietary ExoSCRT™ technology, ExoCoBio produces high-purity, high-efficiency exosome-based solutions that are transforming both the cosmetic and medical industries.
Our Expertise: ExoCoBio operates a cGMP-certified facility to ensure the highest standards of quality and safety.
Innovative Products: From ASCE+ for skin and hair regeneration to next-generation cosmetic ingredients, ExoCoBio is at the forefront of exosome innovation.
Leadership: Led by CEO Byong Cho, ExoCoBio continues to pioneer advancements in exosome technology, improving lives through science.
.png)